| Old Articles: <Older 30451-30460 Newer> |
|---|
 |
The Motley Fool
May 31, 2008
Paul Elliott |
The Real China Miracle, Part 3 This time, you can believe the hype about investing in China. Here's how to play it.   |
The Motley Fool
May 30, 2008
Ryan Fuhrmann |
Tiffany's: A Girl's Best Friend Despite the dull momentum in the retail world these days, upscale jeweler Tiffany's shone through with first-quarter results that sparkled like the jewels. |
The Motley Fool
May 30, 2008
Nick Kapur |
Cramer vs. Your Family Just humor us for a second and answer a few quick questions to determine what type of investor you are. |
The Motley Fool
May 30, 2008
Christopher Barker |
Joy's Global-Sized Growth New orders and surging backlogs continue to establish mining equipment maker Joy Global's growing revenue potential well into the future. |
The Motley Fool
May 30, 2008
Christopher Barker |
Ford Tender Offer Motors Along Billionaire investor Kirk Kerkorian stands by his offer for Ford shares. |
The Motley Fool
May 30, 2008
Tom Hutchinson |
Which Big Banks to Buy One of the most successful ways of making money in the market is by buying good companies in essential industries when they're out of favor. Well, banks are certainly out of favor. |
The Motley Fool
May 30, 2008
Brian Orelli |
For Merck, Hindsight Hurts Even after dragging its feet for years, one has to wonder if Merck settled the Vioxx cases a little too quickly? |
The Motley Fool
May 30, 2008
Tom Hutchinson |
This Week in Banking Many are speculating whether it's time to get back into financial stocks. |
The Motley Fool
May 30, 2008
Brian Lawler |
PDL Shakeup Lifts Shares Shares of PDL BioPharma rise after a longtime board member, currently the company's interim CEO, departs. |
The Motley Fool
May 30, 2008
Brian Orelli |
No Love for Antibiotics From the FDA Wyeth gets an approvable letter for its antibiotic Tygacil. |
| <Older 30451-30460 Newer> Return to current articles. |
